🇺🇸 FDA
Patent

US 11638706

Methods for treating Huntington's disease

granted A61KA61K31/415A61K31/433

Quick answer

US patent 11638706 (Methods for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/415, A61K31/433, A61K31/4439, A61K31/4709